Pharmaceutical Ahead of the current and exciting news coming from ASCO over the weekend, hitting the headlines were Johnson & Johnson’s deal with Protagonist, Novartis setting out its future growth plans, small-cap French drugmaker Nicox gaining its first drug approval in the USA, GlaxoSmithKline filing for approval on a combination HIV treatment and Teva Pharmaceutical Industries’ progress with migraine drug candidate fremanezumab. 4 June 2017